StreetInsider.com News Articles

Form 8-K Mobia Medical, Inc. For: Jul 14

Wed, 15 Jul 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260715/26774241.html

Mobia Medical adds ex-Procept BioRobotics CEO to its board

Wed, 15 Jul 2026 16:05:13 -0400

Mobia Medical, Inc. (Nasdaq: MOBI) announced the appointment of Reza Zadno, Ph.D., to its board of directors as an independent director, effective July 14, 2026. Dr. Zadno will also serve on the company's Compensation Committee.

Dr. Zadno brings more than 35 years of medical technology experience. He most recently served as President and CEO of PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company, from February 2020 to September 2025, leading the company through its 2021 IPO.

Prior to that role, he served as President and CEO of Avedro, a public ophthalmology company, from September 2016 to November 2020, before its acquisition by

Mobia Medical adds ex-Procept BioRobotics CEO to its board

Wed, 15 Jul 2026 16:05:13 -0400

Prior to that role, he served as President and CEO of Avedro, a public ophthalmology company, from September 2016 to November 2020, before its acquisition by

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Wed, 15 Jul 2026 16:05:00 -0400

AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Reza Zadno, Ph.D., to the Board as an independent director, effective July 14, 2026. Dr. Zadno will also serve as a member of the Compensation Committee.

“We are pleased to welcome Reza to the Mobia Medical Board of Directors,” said Richard Foust, President and Chief Executive Officer of Mobia Medical. “He has built and scaled multiple public medical technology companies, and his operational perspective

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Wed, 15 Jul 2026 16:05:00 -0400

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Wed, 15 Jul 2026 16:05:00 -0400

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Wed, 15 Jul 2026 16:05:00 -0400

Mobia Medical publishes two-year stroke recovery data in Neurology

Tue, 14 Jul 2026 16:21:04 -0400

Mobia Medical, Inc. (Nasdaq: MOBI) announced the publication of two-year follow-up data from the VNS-REHAB clinical trial in Neurology, the peer-reviewed journal of the American Academy of Neurology, reporting sustained improvements in upper-limb motor function among chronic ischemic stroke survivors treated with its Vivistim Paired VNS Therapy.

The study followed 49 participants from the original VNS-REHAB pivotal trial. Results showed that 76% of participants achieved a clinically meaningful response on at least one of two standard assessments: the Fugl-Meyer Assessment of Upper Extremity impairment or the Wolf Motor Function Test. Average improvement on the Fugl-Meyer scale was 7.5 points from baseline,

Mobia Medical publishes two-year stroke recovery data in Neurology

Tue, 14 Jul 2026 16:21:04 -0400

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy